Konyne

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1970-2005
012319702005

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Konyne concentrate of Factors II, VII, IX and X has been utilized in the management of a variety of coagulation disorders. Our… (More)
  • table 1
  • table 2
Is this relevant?
1982
1982
A patient with severe congenital factor VII deficiency had an anterior and posterior spine fusion for severe scoliosis. For both… (More)
Is this relevant?
1981
1981
A 17-year-old boy with hemophilia A and strong inhibitors for factor VIII suffered a myocardial infarction on the sixth day of… (More)
Is this relevant?
1979
1979
A case of hemophilia B with hemarthrosis in the TMJ, which led to pain and limitation of jaw movement, was successfully… (More)
Is this relevant?
1977
1977
A hemophilliac with a factor VIII inhibitor was bleeding massively from an extensive surgical wound. After ten days of… (More)
Is this relevant?
1977
1977
There has been no systematic re-examination of variables that may affect the level and duration of response of patients with… (More)
Is this relevant?
1977
1977
HBsAg was detected in two commercial clotting factor concentrates: Proplex (Hyland) and Konyne (Cutter). HBsAg was positive by… (More)
Is this relevant?
1976
1976
Two prothrombin complex concentrates, Auto-Factor IX and Proplex, have been reported to be effective in controlling bleeding in… (More)
Is this relevant?
1976
1976
Thromboembolic complications occurring in patients treated with factor IX concentrates have been reported. To study the… (More)
Is this relevant?
1970
1970
 
Is this relevant?